Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Felbamate monotherapy for partial-onset seizures: an active-control trial

E Faught1, R C Sachdeo, M P Remler

  • 1Department of Neurology, University of Alabama School of Medicine, Birmingham.

Neurology
|April 1, 1993
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Buna Joe "BJ" Wilder, MD (1929-2023).

Neurology·2024
Same author

Face Value: Remote facial expression analysis adds predictive power to perceived effectiveness for selecting anti-tobacco PSAs.

Journal of health communication·2022
Same author

2-Deoxy-d-Glucose (2-DG)-Induced Cardiac Toxicity in Rat: NT-proBNP and BNP as Potential Early Cardiac Safety Biomarkers.

International journal of toxicology·2016
Same author

Corpus callosum area and brain volume in autism spectrum disorder: quantitative analysis of structural MRI from the ABIDE database.

Journal of autism and developmental disorders·2015
Same author

Abstracts of Presentations at the International Conference on Basic and Clinical Multimodal Imaging (BaCI), a Joint Conference of the International Society for Neuroimaging in Psychiatry (ISNIP), the International Society for Functional Source Imaging (ISFSI), the International Society for Bioelectromagnetism (ISBEM), the International Society for Brain Electromagnetic Topography (ISBET), and the EEG and Clinical Neuroscience Society (ECNS), in Geneva, Switzerland, September 5-8, 2013.

Clinical EEG and neuroscience·2013
Same author

Perampanel: expanding therapeutic options for patients with medically refractory secondary generalized convulsive seizures.

Acta neurologica Scandinavica. Supplementum·2013

Felbamate (FBM) monotherapy effectively treated uncontrolled partial-onset seizures compared to valproate (VPA). FBM demonstrated a favorable safety profile with fewer adverse events during monotherapy.

Area of Science:

  • Neurology
  • Clinical Pharmacology

Background:

  • Epilepsy management often involves complex treatment regimens.
  • Partial-onset seizures require effective monotherapy options.

Purpose of the Study:

  • To evaluate the efficacy and safety of felbamate (FBM) monotherapy versus valproate (VPA) in patients with uncontrolled partial-onset seizures.

Main Methods:

  • A multicenter, double-blind, parallel-group trial involving 111 patients.
  • Patients received either FBM 3,600 mg/d or VPA 15 mg/kg/d, with baseline antiepileptic drug (AED) tapering.
  • Efficacy assessed by escape criteria including seizure frequency increase and generalized tonic-clonic seizures (GTCs).

Main Results:

  • Significantly fewer patients on FBM (18) met escape criteria compared to VPA (37) (p < 0.001).

Related Experiment Videos

  • Even accounting for dropouts, FBM showed a statistically significant treatment advantage (p = 0.039).
  • FBM monotherapy was associated with mild to moderate adverse experiences, occurring less frequently than with VPA.
  • Conclusions:

    • Felbamate monotherapy is an effective treatment for partial-onset seizures, including those with secondary generalization.
    • FBM exhibits a favorable safety profile when used as monotherapy for epilepsy management.